PolyPeptide publishes invitation to the annual General Meeting 2022
PolyPeptide Group AG (PolyPeptide), a global leader in peptide custom development and manufacturing, published today the invitation to its first annual General Meeting which will take place on 26 April 2022 in Zug (AGM 2022).
In compliance with the applicable COVID-19 regulations, PolyPeptide will hold its AGM 2022 without the physical presence of shareholders, which means that voting rights can be exercised exclusively via the Independent Proxy. The Board of Directors took this decision with regret, but in the interest of the health and well-being of all participants. Shareholders may submit any statements or questions regarding the proposed agenda items to the Board of Directors between 5 April and 22 April 2022 via email to investorrelations@polypeptide.com.
As communicated on 15 March 2022, the Board of Directors proposes a cash distribution of CHF 0.30 per entitled share, which will be paid out of the foreign capital contribution reserves.
At the AGM 2022, all six current members of the Board of Directors stand for re-election. Peter Wilden is proposed for re-election as Chairman of the Board of Directors, and Philippe Weber and Peter Wilden as members of the Remuneration and Nomination Committee.
A further proposal, among others, is the change of the Company’s registered office from Zug to Baar, Canton of Zug, and the related change of the Company’s Articles of Association.
The invitation to the AGM 2022 with the detailed proposals can be found on the company’s website.
[…]